These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12388863)

  • 1. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for subchronic/chronic toxicity and carcinogenicity testing.
    Combes R; Schechtman L; Stokes WS; Blakey D
    ILAR J; 2002; 43 Suppl():S112-7. PubMed ID: 12388863
    [No Abstract]   [Full Text] [Related]  

  • 2. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute systemic toxicity testing.
    Stitzel KA; Spielmann H; Griffin G
    ILAR J; 2002; 43 Suppl():S108-11. PubMed ID: 12388862
    [No Abstract]   [Full Text] [Related]  

  • 3. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for safety evaluation using nonrodent species.
    Weekley LB; Guittin P; Chamberland G
    ILAR J; 2002; 43 Suppl():S118-22. PubMed ID: 12388864
    [No Abstract]   [Full Text] [Related]  

  • 4. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care committees and animal use oversight.
    Richmond J; Fletch A; Van Tongerloo R
    ILAR J; 2002; 43 Suppl():S129-32. PubMed ID: 12388867
    [No Abstract]   [Full Text] [Related]  

  • 5. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care in regulatory toxicology.
    Morris T; Goulet S; Morton D
    ILAR J; 2002; 43 Suppl():S123-5. PubMed ID: 12388865
    [No Abstract]   [Full Text] [Related]  

  • 6. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for biological: safety and potency evaluations.
    Cussler K; Kulpa J; Calver J
    ILAR J; 2002; 43 Suppl():S126-8. PubMed ID: 12388866
    [No Abstract]   [Full Text] [Related]  

  • 7. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute local skin and eye toxicity testing.
    Botham PA; Hayes AW; Moir D
    ILAR J; 2002; 43 Suppl():S105-7. PubMed ID: 12388861
    [No Abstract]   [Full Text] [Related]  

  • 8. ICH guidelines--implementation of the 3Rs (refinement, reduction, and replacement): incorporating best scientific practices into the regulatory process.
    Ohno Y
    ILAR J; 2002; 43 Suppl():S95-8. PubMed ID: 12388859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP).
    Bregman CL; Adler RR; Morton DG; Regan KS; Yano BL;
    Toxicol Pathol; 2003; 31(2):252-3. PubMed ID: 12696587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germany remains split on animal testing.
    Miller B
    Nature; 1998 Feb; 391(6668):624. PubMed ID: 9490404
    [No Abstract]   [Full Text] [Related]  

  • 13. Possibilities for refinement and reduction: future improvements within regulatory testing.
    Stephens ML; Conlee K; Alvino G; Rowan AN
    ILAR J; 2002; 43 Suppl():S74-9. PubMed ID: 12388856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ICLAS/CCAC International Symposium on Regulatory Testing and Animal Welfare.
    Griffin G; Stokes WS; Pakes SP; Gauthier C
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():707-12. PubMed ID: 23581164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hunting for animal alternatives.
    Roush W
    Science; 1996 Oct; 274(5285):168-71. PubMed ID: 8927974
    [No Abstract]   [Full Text] [Related]  

  • 17. Future improvements and implementation of animal care practices within the animal testing regulatory environment.
    Guittin P; Decelle T
    ILAR J; 2002; 43 Suppl():S80-4. PubMed ID: 12388857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of the meeting on 'animal welfare in regulatory toxicology' under the auspices of the British Toxicology Society, 27 April 1995.
    Farningham DA; Damment SJ; West C
    Hum Exp Toxicol; 1996 May; 15(5):452-4. PubMed ID: 8735471
    [No Abstract]   [Full Text] [Related]  

  • 19. The relevance of genetically altered mouse models of human disease.
    Bhogal N; Combes R
    Altern Lab Anim; 2006 Aug; 34(4):429-54. PubMed ID: 16945009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated alternatives: is immediate implementation required?
    Silverman J
    Lab Anim (NY); 2007 May; 36(5):13. PubMed ID: 17450160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.